Table 1.
Clinical characteristics of PrCa cases that passed quality control
| Non-aggressive | Aggressive | |
|---|---|---|
| Age range | ||
| ≤54 | 0 | 51 |
| 55–59 | 0 | 88 |
| 60–64 | 56 | 0 |
| 65–69 | 50 | 0 |
| ≥70 | 35 | 0 |
| M Stage | ||
| M0 | 141 | 0 |
| M1 | 0 | 139 |
| N Stage | ||
| N0 | 141 | 27 |
| N1 | 0 | 63 |
| Nx | 0 | 49 |
| T Stage | ||
| T1 | 84 | 8 |
| T2 | 57 | 11 |
| T3 | 0 | 67 |
| T4 | 0 | 42 |
| Tx | 0 | 11 |
| Gleason score | ||
| ≤6 | 141 | 8 |
| 7 | 0 | 26 |
| ≥8 | 0 | 79 |
| Unknown | 0 | 26 |
M Stage indicates the presence or absence of distant metastases and N Stage indicates nodal spread; 1 = present, 0 = absent, x = unknown. T Stage refers to the tumour staging according to the TNM staging system